Search For "drug controller"
Dr Reddy's Lab gets emergency use authorisation for Sputnik V in India
Updated : 4 years, 11 months ago IST
Hyderabad (Telangana) [India], April 13 (ANI): Dr Reddy's Laboratories said on Tuesday it has received permission from the Drug Controller General of India (DCGI) to import Sputnik vaccine into India for restricted use in emergency situations.
Read More
Enzene Biosciences Ltd. obtains marketing authorization for its first bios
Updated : 5 years, 1 month ago IST
Pune (Maharashtra) [India], February 4 (ANI/PRNewswire): Recently Enzene Biosciences Ltd. announced that it has obtained Marketing Authorisation (MA) from Drug Controller General of India (DCGI) for Teriparatide - bioactive part of human parathyroid hormone (PTH), an anabolic approach to the
Read More
Equity indices trade strong, Sensex jumps 48K mark
Updated : 5 years, 2 months ago IST
Mumbai (Maharashtra) [India], January 4 (ANI): Equity benchmark indices continued their upward march during early hours on Monday after the Drug Controller General of India approved Covid vaccines produced by AstraZeneca and Bharat Biotech for emergency use in the country.
Read More
Indigenous mRNA vaccine candidate supported by DBT gets Drug Controller no
Updated : 5 years, 3 months ago IST
New Delhi [India], December 11 (ANI): In a major development in the fight against COVID-19, India's first indigenous mRNA vaccine candidate has received approval from Indian Drug regulators to initiate Phase I/II human clinical trial.
Read More
Russian Sputnik V COVID-19 vaccine to be tested on 100 Indian volunteers
Updated : 5 years, 4 months ago IST
Moscow [Russia], October 23 (ANI): The Russian Sputnik V vaccine against COVID-19 will be tested in India on 100 volunteers, the Indian Central Drugs Standard Control Organisation's Drug Controller General (DCGI) told Sputnik on Thursday.
Read More
DCGI approves India's first CRISPR Covid-19 test developed by the Tata Gro
Updated : 5 years, 5 months ago IST
New Delhi [India], September 19 (ANI): The Drug Controller General of India (DCGI), on Saturday gave approval for the commercial launch of India's first Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) test, developed by the Tata Group and CSIR-IGIB (Institute of Genomics a
Read More
Dr Reddy's launches Redyx (Remdesivir) in India for COVID-19 treatment
Updated : 5 years, 6 months ago IST
Hyderabad (Telangana) [India], September 9 (ANI): Dr Reddy's Laboratories on Wednesday announced the launch of Remdesivir under the brand name Redyx for Indian markets.
Read More
Lupin launches Favipiravir in India for COVID treatment at Rs 49 per table
Updated : 5 years, 7 months ago IST
Mumbai (Maharashtra) [India], Aug 5 (ANI): Pharma major Lupin Ltd on Wednesday announced the launch of Favipiravir in India under the brand name Covihalt for treatment of mild to moderate COVID-19.
Read More
Cipla gets regulatory nod for launch of Ciplenza to treat mild to moderate
Updated : 5 years, 7 months ago IST
Mumbai (Maharashtra) [India], July 24 (ANI): Pharmaceutical major Cipla said on Friday it has been granted regulatory approval by the Drug Controller General of India (DCGI) for the launch of Favipiravir in the country under the brand name Ciplenza.
Read More
COVID-19: DCGI nod to Jubilant Generics to manufacture, sell remdesivir f
Updated : 5 years, 7 months ago IST
New Delhi [India], July 20 (ANI): The Drug Controller General of India (DCGI) has granted permission to pharma giant- Jubilant Generics Ltd to manufacture and market the anti-viral drug remdesivir for "restricted emergency use" on hospitalised COVID-19 patients, a senior health ministry offi
Read More
Zydus gets Mexican regulator nod to conduct clinical trials with Pegylated
Updated : 5 years, 8 months ago IST
Ahmedabad (Gujarat) [India], July 17 (ANI): Pharmaceutical major Zydus said on Friday it has got approval from Mexico's Federal Commission for the Protection against Sanitary Risk (COFEPRIS) to conduct clinical trials with its biological therapy 'Pegylated Interferon alpha-2b' for the treatm
Read More
DCGI gives market approval for Pneumococcal Polysaccharide Conjugate Vacci
Updated : 5 years, 8 months ago IST
New Delhi [India], July 15 (ANI): The Drug Controller General of India (DCGI) has given approval to the first fully indigenously developed Pneumococcal Polysaccharide Conjugate Vaccine.
Read More